One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Adalimumab: A ‘Maillon Faible’ in the Treatment of Ulcerative Colitis?Â
doi : 10.1093/ecco-jcc/jjad167
Volume 18, Issue 3, March 2024
Refining the Concept of Microscopic Colitis: HLA Signatures Discriminating Collagenous and Lymphocytic Colitis
doi : 10.1093/ecco-jcc/jjad211
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study
doi : 10.1093/ecco-jcc/jjad156
Human Leukocyte Antigen Signatures as Pathophysiological Discriminants of Microscopic Colitis Subtypes
doi : 10.1093/ecco-jcc/jjad165
Prevalence of Hepatobiliary Manifestations in Inflammatory Bowel Disease: A GRADE Assessed Systematic Review and Meta-Analysis of more than 1.7 Million Patients
doi : 10.1093/ecco-jcc/jjad157
Temporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn’s Disease in the Biologic Era: An Updated Systematic Review with Meta-analysis
doi : 10.1093/ecco-jcc/jjad159
Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases
doi : 10.1093/ecco-jcc/jjad160
Submucosal Injection of the RNA Oligonucleotide GUT-1 in Active Ulcerative Colitis Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2a Induction Trial
doi : 10.1093/ecco-jcc/jjad162
Maintenance Risankizumab Sustains Induction Response in Patients with Crohn’s Disease in a Randomized Phase 3 Trial
doi : 10.1093/ecco-jcc/jjad168
Tofacitinib for Patients with Anti-TNF Refractory Ulcerative Proctitis: A Multicentre Cohort Study from the GETAID
doi : 10.1093/ecco-jcc/jjad169
Baseline Expression of Immune Gene Modules in Blood is Associated With Primary Response to Anti-TNF Therapy in Crohn’s Disease Patients
doi : 10.1093/ecco-jcc/jjad166
NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases
doi : 10.1093/ecco-jcc/jjad164
Patient-reported Outcome Measures in Ileoanal Pouch Surgery: a Systematic Review
doi : 10.1093/ecco-jcc/jjad163
Mitigating the Risk of Tofacitinib-induced Adverse Events in the Elderly Population with Ulcerative Colitis
doi : 10.1093/ecco-jcc/jjad158
6-Mercaptopurine in ulcerative colitis: the potential of upfront dosing with allopurinol
doi : 10.1093/ecco-jcc/jjad150
